The FDA has flagged BPC-157 because of risks like immunogenicity (it could trigger immune reactions), peptide impurities, and lack of human safety data
Skov J, Pedersen M, Holst JJ, Madsen B, Goetze JP, Rittig S, et al
To maintain the results, youll need follow-up treatments
Biodegradable formulations allow gradual resorption of the material after fulfilling their therapeutic role, eliminating the need for surgical retrieval and reducing long-term foreign-body risks [135]
Some products may be manufactured in a factory that also produce gluten, nuts and dairy products.
Aberrant expression of selenium-containing glutathione peroxidases in clear cell renal cell carcinomas